Myriad Genetics
MYGN
#6699
Rank
S$0.85 B
Marketcap
S$9.19
Share price
-3.27%
Change (1 day)
-58.03%
Change (1 year)

Myriad Genetics (MYGN) - Net assets

Net assets on the balance sheet as of September 2025 : S$0.48 Billion

According to Myriad Genetics's latest financial reports the company has S$0.48 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Myriad Genetics - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$S$0.95 B-7.87%
2023-12-31$S$1.03 B-12.9%
2022-12-31$S$1.18 B-9.24%
2021-12-31$S$1.30 B
2020-06-30$S$1.27 B-13.07%
2019-06-30$S$1.47 B11.79%
2018-06-30$S$1.31 B24.54%
2017-06-30$S$1.05 B4.91%
2016-06-30$S$1.00 B12.97%
2015-06-30$S$0.89 B-0.48%
2014-06-30$S$0.89 B-3.05%
2013-06-30$S$0.92 B14.79%
2012-06-30$S$0.80 B15.8%
2011-06-30$S$0.69 B-10.16%
2010-06-30$S$0.77 B23.44%
2009-06-30$S$0.62 B8.28%
2008-06-30$S$0.57 B10.95%
2007-06-30$S$0.52 B31.32%
2006-06-30$S$0.39 B73.06%
2005-06-30$S$0.22 B-22.66%
2004-06-30$S$0.29 B3.48%
2003-06-30$S$0.28 B26.02%
2002-06-30$S$0.22 B-10.45%
2001-06-30$S$0.25 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Bio-Rad Laboratories
BIO
S$8.73 B 1,707.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
S$3.24 B 570.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
S$0.37 M-99.92%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$7.85 B 1,524.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$66.46 B 13,651.07%๐Ÿ‡บ๐Ÿ‡ธ USA